Corvus Pharmaceuticals, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Corvus Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $4.58 million for the year ending 2025.

  • Corvus Pharmaceuticals, Inc. showed a decrease of -47.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Corvus Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
  • XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 12 years of available data (2014 to 2025), Corvus Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 63.4%.
  • Historical annual values: Fiscal year 2025: $4.58 million | Fiscal year 2024: $8.74 million | Fiscal year 2023: $12.62 million | Fiscal year 2022: $13.16 million | Fiscal year 2021: $63.46 million | Fiscal year 2020: $16.46 million | Fiscal year 2019: $5.15 million | Fiscal year 2018: $39.20 million | Fiscal year 2017: $45.11 million | Fiscal year 2016: $5.05 million | Fiscal year 2015: $4.11 million | Fiscal year 2014: $12.52 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: